Opinion

Raffaele Colombo: TROPION-Breast01 results did not achieve statistical significance

Photo from Raffaele Colombo/X

Sep 25, 2024, 16:28

Raffaele Colombo: TROPION-Breast01 results did not achieve statistical significance

Raffaele Colombo shared on X:

“Datopotamab deruxtecan (Dato-DXd) in TROPION-Breast01 did not achieve statistical significance versus chemotherapy.”

Read further.
Source: Raffaele Colombo/X

cancer chemotherapy datopotamab deruxtecan OncoDaily Oncology TROPION-Breast01

April is Head and Neck Cancer Awareness Month

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

Cancer Center Near Me: Dana-Farber Cancer Institute

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Blog

Apr 18, 2025, 20:22

Applications are open for the ESMO Research Fellowship

Blog

Apr 18, 2025, 20:12

Caitríona Duggan: Delighted for the opportunity to share our work at MASCC

Blog

Apr 18, 2025, 20:03

Fumiko Ladd Chino: Honored to be invited to speak about financial toxicity

Blog

Apr 18, 2025, 20:02

Estelamari Rodriguez: ACS NLCRT Biomarker Workshop version of brainstorming with the stars

Blog

Apr 18, 2025, 19:54

Sami Mansfield: Fiber, the microbiome, and cancer care

Blog

Apr 18, 2025, 19:49

Eric K. Singhi Discusses Lung Cancer at ASCO 2025

Science

Apr 18, 2025, 19:44

Nirmala Bhoo Pathy: The need for race and ethnicity data in cancer control

Science

Apr 18, 2025, 19:28

Andreas Charalambous: Achieving digital transformation in cancer care across Europe

Blog

Apr 18, 2025, 19:26

SIOG - Older adults deserve better: Let’s close the gap in Cancer Care

Science

Apr 18, 2025, 19:10

Rafael Grochot: The safety and activity of FGFR inhibitors in early-phase clinical trials

Blog

Apr 18, 2025, 18:58

Mission Adaptation and Mission Cancer: Resilient Health Systems for Cancer - ECHoS

Blog

Apr 18, 2025, 18:55

Robert F. Kennedy Jr. visited U.S. FDA with Commissioner Martin Makary on Medical Innovation